Targeted alpha-particle therapy
Targeted alpha-particle therapy (TAT) is a type of radiation therapy that uses alpha particles to destroy cancer cells. Alpha particles are a type of ionizing radiation that can cause damage to the DNA of cells, leading to cell death. In TAT, these particles are delivered directly to cancer cells, minimizing damage to healthy tissue.
Mechanism of Action[edit | edit source]
The mechanism of action of TAT involves the use of a carrier molecule, typically an antibody, that is designed to bind specifically to a target on the surface of cancer cells. This carrier molecule is linked to a radioactive isotope that emits alpha particles. Once the carrier molecule binds to the cancer cell, the alpha particles are released, causing damage to the cell's DNA and leading to cell death.
Alpha Particles[edit | edit source]
Alpha particles are a type of ionizing radiation that consist of two protons and two neutrons. They have a high linear energy transfer (LET), which means they can cause a large amount of damage to cells in a short distance. This makes them ideal for targeted therapies, as they can destroy cancer cells while minimizing damage to surrounding healthy tissue.
Applications[edit | edit source]
TAT has been investigated for the treatment of a variety of cancers, including prostate cancer, leukemia, and brain tumors. It has shown promise in early clinical trials, particularly for cancers that are difficult to treat with conventional therapies.
Advantages and Disadvantages[edit | edit source]
The main advantage of TAT is its ability to deliver a high dose of radiation directly to cancer cells, minimizing damage to healthy tissue. However, there are also several challenges associated with this therapy. These include the difficulty of targeting the therapy to the correct cells, the potential for radiation damage to healthy tissue, and the need for specialized facilities and personnel to handle the radioactive isotopes.
Future Directions[edit | edit source]
Research is ongoing to improve the effectiveness of TAT and to overcome the challenges associated with this therapy. This includes the development of new carrier molecules and radioactive isotopes, as well as strategies to improve the targeting of the therapy to cancer cells.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD